Patents Represented by Attorney C. M. Caruso
  • Patent number: 5141675
    Abstract: A polyphosphate in combination with an azole such as in alkyl or alkoxy benzotriazole, mercaptobenzothiazole, tolyltriazole, benzotriazole, a substituted benzotriazole and/or 1-phenyl-5-mercaptotetrazole, is used to inhibit the corrosion of metallic surfaces, particularly copper surfaces, in contact with an aqueous system. Systems and compositions are also claimed.
    Type: Grant
    Filed: October 15, 1990
    Date of Patent: August 25, 1992
    Assignee: Calgon Corporation
    Inventors: Daniel P. Vanderpool, Susan P. Rey
  • Patent number: 5128050
    Abstract: A method for controlling zebra mussels in ship ballast tanks comprising treating ballast water which contains zebra mussels or which is prone to zebra mussel infestation with an effective amount of a didecyl dimethyl ammonium halide. A preferred compound is a didecyl dimethyl ammonium chloride.
    Type: Grant
    Filed: May 6, 1991
    Date of Patent: July 7, 1992
    Assignee: Calgon Corporation
    Inventor: Patrick H. Gill
  • Patent number: 5128045
    Abstract: A method for stabilizing metal ions in recirculating water systems is disclosed. This method utilizes an admixture comprising a) an ethylenically unsaturated water-soluble polymer and/or a water soluble phosphonate, b) methylene bis(thiocyanate), and c) 2-(thiocyanomethylthio)benzothiazole to solubilize metal ions thereby reducing deposition and corrosion.
    Type: Grant
    Filed: November 20, 1990
    Date of Patent: July 7, 1992
    Assignee: Calgon Corporation
    Inventors: Jennifer R. Parsons, Beverly Bendiksen, Charles J. Schell
  • Patent number: 5124046
    Abstract: Compositions containing a water soluble carboxylic/sulfonic/polyoxyalkylene terpolymer and a water soluble phosphonate effectively control calcium carbonate scaling in aqueous systems under severe pH, alkalinity, calcite saturation and/or temperature conditions.
    Type: Grant
    Filed: November 16, 1990
    Date of Patent: June 23, 1992
    Assignee: Calgon Corporation
    Inventors: Nancy S. Sherwood, Monica A. Yorke
  • Patent number: 5068279
    Abstract: A melamine-formaldehyde detackifer having less than 0.15% free formaldehyde comprises a melamine-formaldehyde polymer detackifier to which has been added a formaldehyde scavenging agent comprising an effective amount of urea, and an enhancer selected from glyoxal and acetylacetone. The use of the low free formaldehyde detackifier is also described.
    Type: Grant
    Filed: March 30, 1990
    Date of Patent: November 26, 1991
    Assignee: Calgon Corporation
    Inventor: Lewis D. Morse
  • Patent number: 4663307
    Abstract: Novel 6H-dibenz[b,e][1,4]oxathiepin derivatives of the Formulae I and IA are employed in the treatment and control of allergic conditions such as allergic asthma.
    Type: Grant
    Filed: October 1, 1984
    Date of Patent: May 5, 1987
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Yves Girard, Joshua Rokach, Pierre Hamel
  • Patent number: 4634717
    Abstract: The invention relates to novel substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, their analogs and their salts. These compounds are synthesized by methods selected from a number of synthetic routes depending on the particular structure, choice of intermediate or preferred reaction sequence. The compounds are useful for the treatment and prevention of injury to the brain and of edema due to head trauma, stroke (particularly ischemic), arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, cerebral tumors, encephalomyelitis, spinal cord injury, hydrocephalus, post-operative brain injury trauma, edema due to cerebral infections and various brain concussions.
    Type: Grant
    Filed: May 1, 1984
    Date of Patent: January 6, 1987
    Assignee: Merck & Co., Inc.
    Inventors: Edward J. Cragoe, Jr., Otto W. Woltersdorf, Jr.
  • Patent number: 4622403
    Abstract: Novel dibenz[b,f]thiepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma.
    Type: Grant
    Filed: October 11, 1983
    Date of Patent: November 11, 1986
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Haydn Williams, Joshua Rokach